WallStreetZenWallStreetZen

NYSE: CNMD
Conmed Corp Stock Forecast, Predictions & Price Target

Analyst price target for CNMD

Based on 7 analysts offering 12 month price targets for Conmed Corp.
Min Forecast
$119.00+18%
Avg Forecast
$134.71+33.58%
Max Forecast
$145.00+43.78%

Should I buy or sell CNMD stock?

Based on 7 analysts offering ratings for Conmed Corp.
Strong Buy
Strong Buy
4 analysts 57.14%
Buy
2 analysts 28.57%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CNMD stock forecasts and price targets.

CNMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
JP Morgan
Top 21%
80
Strong BuyMaintains$145.00+43.78%2023-07-27
Needham
Bottom 1%
1
BuyMaintains$140.00+38.82%2023-07-27
KeyBanc
Bottom 7%
7
Strong BuyMaintains$141.00+39.81%2023-07-27
CL King
Bottom 14%
14
BuyInitiates Coverage On$140.00+38.82%2023-05-22
Stifel Nicolaus
Top 5%
96
Strong BuyMaintains$130.00+28.90%2023-04-27Find out why
Piper Sandler
Bottom 3%
3
Strong BuyMaintains$128.00+26.92%2023-04-27
Wells Fargo
Top 35%
66
HoldMaintains$119.00+18.00%2023-04-27

1 of 1

Forecast return on equity

Is CNMD forecast to generate an efficient return?
Company
20.17%
Industry
22.69%
Market
58.05%
CNMD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CNMD forecast to generate an efficient return on assets?
Company
6.78%
Industry
11.72%
CNMD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CNMD earnings growth forecast

How is CNMD forecast to perform vs Medical Devices companies and vs the US market?
Company
22.85%
Industry
50.13%
Market
21.9%
CNMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CNMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CNMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CNMD revenue growth forecast

How is CNMD forecast to perform vs Medical Devices companies and vs the US market?
Company
7.91%
Industry
6.71%
Market
7.96%
CNMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CNMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CNMD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
CNMD$100.85$134.71+33.58%Strong Buy
IART$38.19$47.83+25.25%Sell
IRTC$94.26$133.00+41.10%Strong Buy
LIVN$52.88$56.80+7.41%Hold
AXNX$56.12$73.67+31.27%Strong Buy

Conmed Stock Forecast FAQ

Is Conmed Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NYSE: CNMD) stock is to Strong Buy CNMD stock.

Out of 7 analysts, 4 (57.14%) are recommending CNMD as a Strong Buy, 2 (28.57%) are recommending CNMD as a Buy, 1 (14.29%) are recommending CNMD as a Hold, 0 (0%) are recommending CNMD as a Sell, and 0 (0%) are recommending CNMD as a Strong Sell.

If you're new to stock investing, here's how to buy Conmed stock.

What is CNMD's forecast return on equity (ROE) for 2023-2025?

(NYSE: CNMD) forecast ROE is 20.17%, which is considered strong.

What is CNMD's Price Target?

According to 7 Wall Street analysts that have issued a 1 year CNMD price target, the average CNMD price target is $134.71, with the highest CNMD stock price forecast at $145.00 and the lowest CNMD stock price forecast at $119.00.

On average, Wall Street analysts predict that Conmed's share price could reach $134.71 by Jul 27, 2024. The average Conmed stock price prediction forecasts a potential upside of 33.58% from the current CNMD share price of $100.85.

What is CNMD's forecast return on assets (ROA) for 2023-2025?

(NYSE: CNMD) forecast ROA is 6.78%, which is lower than the forecast US Medical Devices industry average of 11.72%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.